229 related articles for article (PubMed ID: 22515372)
1. Biomonitoring of aristolactam-DNA adducts in human tissues using ultra-performance liquid chromatography/ion-trap mass spectrometry.
Yun BH; Rosenquist TA; Sidorenko V; Iden CR; Chen CH; Pu YS; Bonala R; Johnson F; Dickman KG; Grollman AP; Turesky RJ
Chem Res Toxicol; 2012 May; 25(5):1119-31. PubMed ID: 22515372
[TBL] [Abstract][Full Text] [Related]
2. Human formalin-fixed paraffin-embedded tissues: an untapped specimen for biomonitoring of carcinogen DNA adducts by mass spectrometry.
Yun BH; Rosenquist TA; Nikolić J; Dragičević D; Tomić K; Jelaković B; Dickman KG; Grollman AP; Turesky RJ
Anal Chem; 2013 May; 85(9):4251-8. PubMed ID: 23550627
[TBL] [Abstract][Full Text] [Related]
3. Multiclass Carcinogenic DNA Adduct Quantification in Formalin-Fixed Paraffin-Embedded Tissues by Ultraperformance Liquid Chromatography-Tandem Mass Spectrometry.
Guo J; Yun BH; Upadhyaya P; Yao L; Krishnamachari S; Rosenquist TA; Grollman AP; Turesky RJ
Anal Chem; 2016 May; 88(9):4780-7. PubMed ID: 27043225
[TBL] [Abstract][Full Text] [Related]
4. New Approaches for Biomonitoring Exposure to the Human Carcinogen Aristolochic Acid.
Yun BH; Sidorenko VS; Rosenquist TA; Dickman KG; Grollman AP; Turesky RJ
Toxicol Res (Camb); 2015 Jul; 4(4):763-776. PubMed ID: 26366284
[TBL] [Abstract][Full Text] [Related]
5. Aristolactam I a metabolite of aristolochic acid I upon activation forms an adduct found in DNA of patients with Chinese herbs nephropathy.
Stiborová M; Frei E; Breuer A; Bieler CA; Schmeiser HH
Exp Toxicol Pathol; 1999 Jul; 51(4-5):421-7. PubMed ID: 10445409
[TBL] [Abstract][Full Text] [Related]
6. Quantification of aristolochic acid-derived DNA adducts in rat kidney and liver by using liquid chromatography-electrospray ionization mass spectrometry.
Chan W; Yue H; Poon WT; Chan YW; Schmitz OJ; Kwong DW; Wong RN; Cai Z
Mutat Res; 2008 Nov; 646(1-2):17-24. PubMed ID: 18812181
[TBL] [Abstract][Full Text] [Related]
7. Screening DNA Damage in the Rat Kidney and Liver by Untargeted DNA Adductomics.
Ragi N; Walmsley SJ; Jacobs FC; Rosenquist TA; Sidorenko VS; Yao L; Maertens LA; Weight CJ; Balbo S; Villalta PW; Turesky RJ
Chem Res Toxicol; 2024 Feb; 37(2):340-360. PubMed ID: 38194517
[TBL] [Abstract][Full Text] [Related]
8. A novel and specific method for the determination of aristolochic acid-derived DNA adducts in exfoliated urothelial cells by using ultra performance liquid chromatography-triple quadrupole mass spectrometry.
Guo L; Wu H; Yue H; Lin S; Lai Y; Cai Z
J Chromatogr B Analyt Technol Biomed Life Sci; 2011 Jan; 879(2):153-8. PubMed ID: 21177145
[TBL] [Abstract][Full Text] [Related]
9. Exceptionally long-term persistence of DNA adducts formed by carcinogenic aristolochic acid I in renal tissue from patients with aristolochic acid nephropathy.
Schmeiser HH; Nortier JL; Singh R; Gamboa da Costa G; Sennesael J; Cassuto-Viguier E; Ambrosetti D; Rorive S; Pozdzik A; Phillips DH; Stiborova M; Arlt VM
Int J Cancer; 2014 Jul; 135(2):502-7. PubMed ID: 24921086
[TBL] [Abstract][Full Text] [Related]
10. Noninvasive measurement of aristolochic acid-DNA adducts in urine samples from aristolochic acid-treated rats by liquid chromatography coupled tandem mass spectrometry: evidence for DNA repair by nucleotide-excision repair mechanisms.
Leung EM; Chan W
Mutat Res; 2014; 766-767():1-6. PubMed ID: 25847264
[TBL] [Abstract][Full Text] [Related]
11. Aristolactam-DNA adducts are a biomarker of environmental exposure to aristolochic acid.
Jelaković B; Karanović S; Vuković-Lela I; Miller F; Edwards KL; Nikolić J; Tomić K; Slade N; Brdar B; Turesky RJ; Stipančić Ž; Dittrich D; Grollman AP; Dickman KG
Kidney Int; 2012 Mar; 81(6):559-67. PubMed ID: 22071594
[TBL] [Abstract][Full Text] [Related]
12. Aristolochic acid and the etiology of endemic (Balkan) nephropathy.
Grollman AP; Shibutani S; Moriya M; Miller F; Wu L; Moll U; Suzuki N; Fernandes A; Rosenquist T; Medverec Z; Jakovina K; Brdar B; Slade N; Turesky RJ; Goodenough AK; Rieger R; Vukelić M; Jelaković B
Proc Natl Acad Sci U S A; 2007 Jul; 104(29):12129-34. PubMed ID: 17620607
[TBL] [Abstract][Full Text] [Related]
13. 32P-post-labelling analysis of DNA adducts formed by aristolochic acid in tissues from patients with Chinese herbs nephropathy.
Bieler CA; Stiborova M; Wiessler M; Cosyns JP; van Ypersele de Strihou C; Schmeiser HH
Carcinogenesis; 1997 May; 18(5):1063-7. PubMed ID: 9163697
[TBL] [Abstract][Full Text] [Related]
14. Targeted and Untargeted Detection of DNA Adducts of Aromatic Amine Carcinogens in Human Bladder by Ultra-Performance Liquid Chromatography-High-Resolution Mass Spectrometry.
Guo J; Villalta PW; Weight CJ; Bonala R; Johnson F; Rosenquist TA; Turesky RJ
Chem Res Toxicol; 2018 Dec; 31(12):1382-1397. PubMed ID: 30387604
[TBL] [Abstract][Full Text] [Related]
15. Analyses of DNA adducts formed by ochratoxin A and aristolochic acid in patients with Chinese herbs nephropathy.
Arlt VM; Pfohl-Leszkowicz A; Cosyns J; Schmeiser HH
Mutat Res; 2001 Jul; 494(1-2):143-50. PubMed ID: 11423353
[TBL] [Abstract][Full Text] [Related]
16. Carcinogenic and nephrotoxic alkaloids aristolochic acids upon activation by NADPH : cytochrome P450 reductase form adducts found in DNA of patients with Chinese herbs nephropathy.
Stiborová M; Hájek M; Frei E; Schmeiser HH
Gen Physiol Biophys; 2001 Dec; 20(4):375-92. PubMed ID: 11989648
[TBL] [Abstract][Full Text] [Related]
17. Novel LC-ESI/MS/MS(n) method for the characterization and quantification of 2'-deoxyguanosine adducts of the dietary carcinogen 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine by 2-D linear quadrupole ion trap mass spectrometry.
Goodenough AK; Schut HA; Turesky RJ
Chem Res Toxicol; 2007 Feb; 20(2):263-76. PubMed ID: 17305409
[TBL] [Abstract][Full Text] [Related]
18. Carcinogenic aristolochic acids upon activation by DT-diaphorase form adducts found in DNA of patients with Chinese herbs nephropathy.
Stiborová M; Frei E; Sopko B; Wiessler M; Schmeiser HH
Carcinogenesis; 2002 Apr; 23(4):617-25. PubMed ID: 11960915
[TBL] [Abstract][Full Text] [Related]
19. Aristolochic acid-associated urothelial cancer in Taiwan.
Chen CH; Dickman KG; Moriya M; Zavadil J; Sidorenko VS; Edwards KL; Gnatenko DV; Wu L; Turesky RJ; Wu XR; Pu YS; Grollman AP
Proc Natl Acad Sci U S A; 2012 May; 109(21):8241-6. PubMed ID: 22493262
[TBL] [Abstract][Full Text] [Related]
20. Evidence of exposure to aristolochic acid in patients with urothelial cancer from a Balkan endemic nephropathy region of Romania.
Schmeiser HH; Kucab JE; Arlt VM; Phillips DH; Hollstein M; Gluhovschi G; Gluhovschi C; Modilca M; Daminescu L; Petrica L; Velciov S
Environ Mol Mutagen; 2012 Oct; 53(8):636-41. PubMed ID: 22987305
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
